Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Convertible Debt (2023)

Historic Convertible Debt for Serina Therapeutics (SER) over the last 1 years, with Q4 2023 value amounting to $3.0 million.

  • Serina Therapeutics' Convertible Debt changed N/A to $3.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, Serina Therapeutics' Convertible Debt is $3.0 million.
  • Over the past 5 years, Serina Therapeutics' Convertible Debt peaked at $3.0 million during Q4 2023, and registered a low of $3.0 million during Q4 2023.